Category Archives: Uncategorized

Friday, August 21, 2020 RSVP required This will be offered as webex webinar. Agenda (all times are MDT) (subject to change) 10:45 am                    Gathering/Welcome/Introductions Denise Donnelly, FRaBSA President 11:00 am                    Business Meeting-Denise Donnelly, FRaBSA President 11:30-12:00 pm          TSS … Continue reading →

FRaBSA will host a virtual symposium.                                                                             SAVE THE DATE More detail to come on: CM Points Confirmed Speakers/Topics To Date:                – David Gillum, ABSA International President: ABSA introduction, First COVID-19; reopening ASU                – Roundtable: Industry/start-up companies associated with … Continue reading →

We would love to have you join us.  Save money now for the Fall Symposium. Dues are now due July 1 of each year for the time frame of  July 1 2020 to June 30 2021 Benefits of Membership: Networking … Continue reading →

FRaBSA held a COVID-19 webinar on 4-24-20. This webinar was well attended with over 300 attendees representing universities, public agencies, private companies and even a few Canadians. A recording of this webinar is available on FRaBSA’s youtube channel: Questions?   … Continue reading →

April 25, 2019, the National Institutes of Health (NIH) finalized a proposal to amend the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) to streamline the oversight of gene therapy research. This proposal, which was … Continue reading →

The FRaBSA Inaugural Biosafety Symposium was held September 29, 2017 in Boulder, CO. Agenda and links to the video are available in the members only section. click here

http://www.hhs.gov/news/press/2015pres/06/20150612b.html HHS selects nine regional Ebola and other special pathogen treatment centers • Colorado Department of Public Health and Environment in partnership with Denver Health Medical Center in Denver, Colorado